SUMMARY: BOLD fMRI has, during the past decade, made a major transition from a purely research imaging technique to a viable clinical technique used primarily for presurgical planning in patients with brain tumors and other resectable brain lesions. This review article briefly examines the history and evolution of clinical functional imaging, with particular emphasis on how the use of BOLD fMRI for neurosurgical planning has changed during the past 2 decades. Even more important, this article describes the many published studies during that same period that have examined the overall clinical impact that BOLD and DTI have made on surgical planning.ABBREVIATIONS: AF ϭ arcuate fasciculus; ASFNR ϭ American Society of Functional Neuroradiology; BOLD ϭ blood oxygen levelϪdependent; CPT ϭ current procedural terminology; CPU ϭ central processing unit; CSM ϭ intraoperative cortical stimulation mapping; DTI ϭ diffusion tensor imaging; DTT ϭ diffusion tensor tractography; EPI ϭ echo-planar imaging; FA ϭ fractional anisotropy; FDA ϭ US Food and Drug Administration; fMRI ϭ functional MR imaging; GLM ϭ general linear model; MEG ϭ magnetoencephalography; PACS ϭ picture archiving and communication system; QC ϭ quality control; RAM ϭ random access memory; SPM ϭ Statistical Parametric Mapping; TL ϭ temporal lobe; TLE ϭ temporal lobe epilepsy; Wada ϭ intracarotid sodium amobarbital test f MRI is a physiologic imaging technique that has rapidly evolved since the early 1990s when Ogawa et al 1-3 first described the BOLD principle, which was based on animal imaging studies and was considered novel. Human imaging applications arose only in 1991, when Belliveau et al 4 described mapping of the human visual cortex by using fMRI. Since those early days, fMRI has burgeoned into one of the most useful research techniques in modern cognitive neuroscience, with use by a wide variety of researchers in fields as diverse as psychology, neurology, psychiatry, and linguistics. However, clinical use of fMRI is a relatively recent phenomenon, with only slightly more than a decade of collective experience. This review article examines the history and evolution of clinical functional imaging, with special emphasis on BOLD and, to a lesser extent, DTI applications in clinical brain tumor imaging, which have served as early models for the clinical translation and maturation of these imaging modalities. In addition, this article describes the clinical impact that BOLD and DTI have made on surgical planning.The ASFNR was established in 2004 to address the unique concerns relating to clinical use of functional imaging, comprising not only BOLD imaging but also DTI, perfusion imaging, MEG/magnetic source imaging, and molecular and metabolic imaging, including MR spectroscopy. As all of these physiologic imaging modalities enter mainstream clinical neuroradiology, a growing need to establish national standards for their clinical use and standardized quality control metrics has emerged. The ASFNR, by planned launch of a multicenter study that will assess the...